Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2017-02-13 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于重大资产重组停牌期满申请延期复牌的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the extension of a trading suspension period due to a major asset restructuring (重大资产重组). It details the progress and reasons for the continued suspension of stock trading while the restructuring plan is being finalized. The document does not contain actual financial statements or detailed financial analysis but rather updates on the status of the restructuring and regulatory compliance. It is a regulatory announcement related to capital restructuring activities but does not itself constitute a full capital/financing update report or a merger/acquisition filing. Given the nature of the content and the absence of detailed financial data, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including announcements about major asset restructurings and related trading suspensions.
2017-02-13 Chinese
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the progress of a major asset restructuring (重大资产重组停牌进展公告) and the continued suspension of trading of the company's stock due to this ongoing major asset reorganization. It references previous announcements and states that updates will be provided every five trading days. The document is short (857 characters) and serves as a progress update on a specific corporate event rather than a full financial report or detailed filing. It does not contain financial statements or detailed analysis but is an official regulatory announcement about the status of a capital restructuring event. Therefore, it fits best under Capital/Financing Update (CAP).
2017-02-09 Chinese
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring and the related stock trading suspension. It references multiple previous announcements about the suspension and progress updates, indicating ongoing disclosure about a significant corporate event. The text does not contain financial statements or detailed financial data but is an update on the status of a major asset reorganization and stock suspension. This fits the category of a Capital/Financing Update (CAP), as it relates to significant corporate financing or restructuring activities and their impact on stock trading.
2017-02-02 Chinese
关于重大资产重组停牌进展公告
M&A Activity Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring and the related stock trading suspension. It mentions multiple prior announcements about the suspension and progress updates, and states that further progress announcements will be made every five trading days. The content focuses on the status of a significant corporate transaction (major asset restructuring) and stock suspension, which aligns with updates on merger or acquisition activities. The document is short (790 characters) and is an announcement of ongoing developments rather than a full detailed report or financial statements. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2017-01-19 Chinese
关于重大资产重组停牌进展暨延期复牌公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress and extension of a trading suspension due to a major asset restructuring. It details the reasons for the suspension, the parties involved, the nature of the transaction, and the expected timeline for resumption of trading. The document does not contain actual financial statements or detailed financial analysis but is an update on the status of a corporate action (major asset restructuring) and the related stock trading suspension and resumption plans. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or earnings release. It is an official announcement related to capital restructuring and trading suspension. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about the capital restructuring progress, not just a notice of report publication or certification, so it is not RPA or RNS.
2017-01-12 Chinese
2016年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2016 annual performance forecast (业绩预告) for Quantum Hi-Tech (量子高科), covering the period from January 1, 2016 to December 31, 2016. It provides estimated net profit figures and notes that the data is unaudited and preliminary, with detailed results to be disclosed in the 2016 annual report. The document is short (645 characters) and serves as a performance forecast announcement rather than a full annual report or earnings release. It does not contain actual financial statements or detailed analysis, only a forecast and cautionary notes. Therefore, it fits best into the category of Earnings Release (ER), which includes initial announcements of periodic financial results or forecasts.
2017-01-11 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.